Cite
E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy
MLA
Samuel S. Murray, et al. E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-Small Cell Lung Cancer Treated With Chemoradiotherapy. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75cc8abbfd8c288da75b3bf252c885e9&authtype=sso&custid=ns315887.
APA
Samuel S. Murray, Dimitrios Ntaskagiannis, Ioannis Sainis, Pericles Tsekeris, Pinelopi Gkogkou, Asimo Demou, Evangelia Peponi, Evangelos Briasoulis, & Elli Ioakeim. (2020). E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-small Cell Lung Cancer Treated With Chemoradiotherapy.
Chicago
Samuel S. Murray, Dimitrios Ntaskagiannis, Ioannis Sainis, Pericles Tsekeris, Pinelopi Gkogkou, Asimo Demou, Evangelia Peponi, Evangelos Briasoulis, and Elli Ioakeim. 2020. “E-Cadherin and Syndecan-1 Expression in Patients With Advanced Non-Small Cell Lung Cancer Treated With Chemoradiotherapy,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....75cc8abbfd8c288da75b3bf252c885e9&authtype=sso&custid=ns315887.